ABCB1 rs1045646: What Your Genotype Means
The rs1045646 variant is a common single nucleotide polymorphism located within the ABCB1 gene. It is frequently studied for its potential association with variations in how the body processes and transports certain medications.
What each genotype means
Typical transporter activity
This genotype is often considered the reference state for the ABCB1 gene. Research into how this specific genotype influences drug efflux is inconsistent, and clinical evidence remains limited. Please discuss any concerns regarding medication response or dosing with your clinician or pharmacist.
This is a common genotype found across most global populations.
Varied transporter activity
Carrying one copy of the T allele may influence the function of the ABCB1 efflux pump, though studies have shown mixed results regarding its impact on drug pharmacokinetics. Because the evidence is limited and inconsistent, this genotype should not be used to make independent medical decisions. Always consult your healthcare provider regarding your specific medication regimen.
This heterozygous genotype is frequently observed in diverse populations worldwide.
Potential altered transporter activity
Some research suggests that this genotype may be associated with differences in how the body processes certain drugs that are substrates for the ABCB1 protein, potentially affecting drug exposure. However, the scientific literature is inconsistent, and the clinical significance of this variation is not well-established. Please discuss your medication response and any necessary dosing adjustments with your clinician.
This genotype is common and present in a significant portion of the population across various ancestries.
Understanding the rs1045646 Variant
The rs1045646 variant is a specific change in the DNA sequence of the ABCB1 gene. In genetics, a single nucleotide polymorphism, or SNP, represents a variation at a single position in the DNA code. This particular variant is located within the coding region of the gene, which provides the instructions for building a protein. Because it sits in a functional part of the gene, researchers have long investigated whether this change alters the structure or efficiency of the resulting protein. While it is a well-documented marker in genetic databases, it is important to note that the presence of this variant does not inherently indicate a health condition. Instead, it is a piece of biological information that scientists use to understand why individuals may respond differently to various environmental factors, including pharmaceutical treatments.
The Role of the ABCB1 Gene
The ABCB1 gene, also known as the MDR1 gene, encodes a protein called P-glycoprotein. This protein acts as an efflux transporter, functioning like a molecular pump that moves substances across cell membranes. P-glycoprotein is found in many tissues throughout the body, including the lining of the intestines, the liver, the kidneys, and the blood-brain barrier. Its primary job is to protect cells by pumping out toxins and foreign substances. Because many medications are also recognized by this pump, P-glycoprotein can influence how much of a drug enters the bloodstream or reaches specific organs. When the ABCB1 gene functions normally, it helps maintain the balance of substances within cells. Variations in this gene are of interest to pharmacogenomics researchers because they may influence the activity levels of this pump, potentially affecting the concentration of drugs in the body.
Research and Clinical Evidence
Research into rs1045646 has primarily focused on its role in pharmacokinetics—the study of how the body absorbs, distributes, and eliminates drugs. Numerous studies have explored whether this SNP correlates with different drug levels in patients taking substrates of P-glycoprotein. However, the evidence regarding its clinical impact remains limited and often inconsistent. While some studies suggest associations with drug response or toxicity, others have found no significant effect. The complexity of drug metabolism means that many factors, including other genes, diet, and overall health, also play a role. Because the findings are mixed and often depend on the specific drug or population being studied, this variant is not currently used as a definitive tool for routine clinical decision-making. It remains a subject of active scientific inquiry rather than a standard diagnostic marker.
Population Frequency
The rs1045646 variant is considered a common polymorphism, meaning it is found at significant frequencies across diverse human populations globally. Because it is widespread, it is frequently encountered in genetic research studies and consumer genetic testing reports.
Navigating Genetic Information
If you have received information about your rs1045646 genotype, it is important to view it within the context of current scientific understanding. This variant is not a predictor of disease, nor is it a reliable indicator of how you will respond to any specific medication. Genetic associations are statistical in nature and do not account for the many other variables that influence your health. You should never use this information to make changes to your prescribed medications or dosages. If you are curious about how your genetics might relate to your health or a specific treatment plan, the best course of action is to consult with your physician or a pharmacist. They are equipped to interpret your medical history alongside any genetic data and can provide guidance that is safe, personalized, and grounded in clinical evidence.
How common is this variant?
The rs1045646 variant is common across global populations, with both the C and T alleles appearing at significant frequencies in most ancestral groups.
Frequently asked questions
Does rs1045646 mean I have a drug resistance?
No, this variant does not mean you have drug resistance. While it is studied in the context of drug transport, the evidence is not strong enough to predict how an individual will respond to any specific medication.
Should I change my medication based on this SNP?
You should never change your medication or dosage based on genetic test results. Always consult your doctor or pharmacist before making any changes to your treatment plan.
Is rs1045646 a disease-causing mutation?
No, rs1045646 is a common genetic variation, not a disease-causing mutation. It is a normal part of human genetic diversity.
Where can I find more information about ABCB1?
You can find reliable information about the ABCB1 gene and its functions through resources like MedlinePlus Genetics or the NCBI Gene database. These sites provide comprehensive, peer-reviewed summaries.
Sources & further reading
Educational information only, last refreshed 9/24/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs1045646?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants in ABCB1
A variant associated with potential differences in drug absorption and clinical outcomes in patients undergoing specific pharmacological therapies.
Nonsynonymous variant (Ala893Ser/Thr) in ABCB1/MDR1 altering P-glycoprotein transporter kinetics and plasma concentrations of drugs such as digoxin, fexofenadine, and tacrolimus.
Synonymous polymorphism in the ABCB1 (MDR1) transporter gene influencing substrate drug efflux and systemic drug exposure.
Synonymous exon 26 variant in ABCB1 linked to altered mRNA stability and variable response to multiple cardiovascular medications.
A variant in the ABCB1 gene associated with potential differences in drug transport across the blood-brain barrier, though clinical impact on antidepressant efficacy remains debated.
This SNP is part of a tight linkage block in the ABCB1 gene that may influence drug response, though studies on its clinical utility in depression have yielded conflicting results.